卵巢子宫内膜样癌。回顾性研究。

Endometrioid carcinoma of the ovary. Retrospective study.

作者信息

Garzetti G G, Ciavattini A, Goteri G, De Nictolis M, Cignitti M, Tranquilli A L, Romanini C

机构信息

Department of Gynecology and Obstetrics University of Ancona, Italy.

出版信息

Eur J Gynaecol Oncol. 1993;14(1):51-5.

PMID:8472733

Abstract

From 1985 to 1991, 9 patients with endometrioid carcinoma of the ovary were treated and followed at the University of Ancona, Department of Gynecology and Obstetrics. Four patients (44.4%) had Stage I disease, 1 (11.1%) Stage II, 1 (11.1%) Stage III and 3 (33.3%) Stage IV. Six patients (66.6%) had grade 2 of the disease and 3 (33.3%) grade 3. Two of the patients (22.2%) had synchronous endometrial carcinoma while 3 had histologic evidence of endometriosis at the time of presentation. All the patients received treatment of combination of surgery, polychemotherapy, hormone and/or immunotherapy. The overall survival rate after a median follow up of 26.6 months was 66.6%. A high survival (100%) was observed for patients with associated endometriosis.

摘要

1985年至1991年期间，安科纳大学妇产科对9例卵巢子宫内膜样癌患者进行了治疗并随访。4例（44.4%）为Ⅰ期疾病，1例（11.1%）为Ⅱ期，1例（11.1%）为Ⅲ期，3例（33.3%）为Ⅳ期。6例（66.6%）为2级疾病，3例（33.3%）为3级。2例（22.2%）患者同时患有子宫内膜癌，3例在就诊时有子宫内膜异位症的组织学证据。所有患者均接受了手术、多药化疗、激素和/或免疫治疗的联合治疗。中位随访26.6个月后的总生存率为66.6%。伴有子宫内膜异位症的患者生存率较高（100%）。